Inozyme Pharma, Inc. Gains 178.17%

Fri, May 16, 2025 at 06:53 PM

Inozyme Pharma, Inc. (INZY:NASDAQ) soared at $3.95, a gain of 178.2%. On Fri, May 16, 2025, INZY:NASDAQ hit a New 2-Week High of $3.95. The stock got featured on our News Catalysts scanner on Fri, May 16, 2025 at 01:43 PM in the 'ACQUISITION' category. From Fri, May 02, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days

About Inozyme Pharma, Inc. (INZY:NASDAQ)

Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and...

Top 10 Gainers:

Affimed N.V. (AFMD:NASDAQ), 227.85%
Inozyme Pharma, Inc. (INZY:NASDAQ), 178.17%
Hempacco Co., Inc. (HPCO:NASDAQ), 87.5%
Siyata Mobile Inc. (SYTA:NASDAQ), 75%
DeFi Development Corp. (DFDV:NASDAQ), 74.45%
Amesite Inc. (AMST:NASDAQ), 50%
NWTN Inc. (NWTN:NASDAQ), 48.41%
Virgin Galactic Holdings, Inc. (SPCE:NYSE), 43.28%
Biodesix, Inc. (BDSX:NASDAQ), 36.91%
Agape ATP Corporation (ATPC:NASDAQ), 36.67%